Difference between revisions of "CTSC:RSNA 12/01/09"
From NAMIC Wiki
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
Back to [[Collaboration:Harvard_CTSC|Collaboration:Harvard_CTSC]] | Back to [[Collaboration:Harvard_CTSC|Collaboration:Harvard_CTSC]] | ||
<br> | <br> | ||
| − | =[[Events:RSNA_CTSA_2009| | + | =[[Events:RSNA_CTSA_2009|Click on this title for the events webpage]]= |
'''The objectives of the workshop are''': | '''The objectives of the workshop are''': | ||
| Line 21: | Line 21: | ||
* 60 min (Jeff Yap+ others): Description and hands-on interactive demo for each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials (e.g. RSNA QIBA) | * 60 min (Jeff Yap+ others): Description and hands-on interactive demo for each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials (e.g. RSNA QIBA) | ||
**DCE-MRI (pre/post-therapy breast tumor perfusion) | **DCE-MRI (pre/post-therapy breast tumor perfusion) | ||
| − | **volumetric CT (e.g. lung tumor segmentation and volumetric measurement | + | **volumetric CT (e.g. lung tumor segmentation and volumetric measurement) |
**FDG-PET/CT (pre/post-therapy whole-body imaging with SUV quantification). | **FDG-PET/CT (pre/post-therapy whole-body imaging with SUV quantification). | ||
Latest revision as of 15:58, 10 November 2009
Home < CTSC:RSNA 12 < 01 < 09Back to Collaboration:Harvard_CTSC
Click on this title for the events webpage
The objectives of the workshop are:
- to enhance interpretation of DICOM images through the use of 3D visualization and analysis
- to gain experience with interactive, quantitative assessment of complex anatomical structures and functional images
- to present current directions of quantitative imaging as a biomarker in clinical trials
Upon completion of this course, participants should be able to
- Describe the methods used for basic analysis of quantitative imaging parameters
- Describe the principles of image registration, segmentation, and volume measurement, and select and use appropriate software for 3D reconstruction
- Identify key analysis and acquisition requirements for multi-center quantitative studies
- Evaluate the impact of quantitative analysis methodology on their research interest
Workshop outline
- 15 min (Kasia Macura): Overview of imaging biomarkers and their use in clinical trials
- 15 min (Randy Gollub): Generic principles of image registration, segmentation, visualization (technical aspects)
- 60 min (Jeff Yap+ others): Description and hands-on interactive demo for each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials (e.g. RSNA QIBA)
- DCE-MRI (pre/post-therapy breast tumor perfusion)
- volumetric CT (e.g. lung tumor segmentation and volumetric measurement)
- FDG-PET/CT (pre/post-therapy whole-body imaging with SUV quantification).
